4//SEC Filing
Barnett Brian Gill 4
Accession 0001493152-19-006198
CIK 0001362703other
Filed
Apr 29, 8:00 PM ET
Accepted
Apr 30, 5:52 PM ET
Size
6.1 KB
Accession
0001493152-19-006198
Insider Transaction Report
Form 4
Barnett Brian Gill
Chief Executive Officer
Transactions
- Award
Employee Stock Option (right to buy)
2019-04-24+8,347,245→ 8,347,245 totalExercise: $0.01From: 2020-01-09Exp: 2029-04-24→ Common Stock (8,347,245 underlying)
Footnotes (3)
- [F1]This terms of this grant were included in the reporting person's employment agreement entered into on December 24, 2018 but the grant was not effective until April 24, 2019.
- [F2]One-third of the Stock Options vest on January 9, 2020, January 9, 2021 and January 9, 2022.
- [F3]Options issued as compensation approved by the Issuer's Board of Directors.
Documents
Issuer
OncBioMune Pharmaceuticals, Inc
CIK 0001362703
Entity typeother
Related Parties
1- filerCIK 0001763358
Filing Metadata
- Form type
- 4
- Filed
- Apr 29, 8:00 PM ET
- Accepted
- Apr 30, 5:52 PM ET
- Size
- 6.1 KB